Mini-monovision with multifocal presbyLASIK for myopic presbyopes

Xiaoxiong Wang,Yiqiao Xing,Xiaojiao Liu
DOI: https://doi.org/10.3923/javaa.2012.2097.2105
2012-01-01
Journal of Animal and Veterinary Advances
Abstract:To evaluate the outcomes of mini-monovision peripheral presbyLASIK in presbyopic myopes. Twenty eight subjects (56 eyes) were included in this prospective study. The mean age of the cohort was 51 years (range, 45-62 years). Mean Spherical Equivalent refraction (SE) of the dominant eyes was -7.00 +/- 2.04D (range, -11.00 to -4.00D) and -7.11 +/- 1.99D (range, -11.13 to -4.25D) for non-dominant eyes. Mini-monovision peripheral presbyLASIK was performed with the dominant eye corrected for distance vision and the non-dominant eye for near vision using the NIDEK EC-5000 CX alpha excimer laser. The target refraction was -0.25D for the dominant eyes and -0.75D for the non-dominant eyes. Data are reported for the last postoperative visit (6 months or later). The mean postoperative SE was -0.58 +/- 0.45D (range, -1.38 to +0.50D) with 71% within +/- 0.50D of the intended SE for the dominant eyes. In the non-dominant eyes, mean postoperative SE was -1.00 +/- 0.44D (range, -1.75 to OD) with 71% within. +/- 0.50D of the intended SE. All subjects achieved binocular Uncorrected Distance Visual Acuity (UDVA) of 0.8 or better, 82% achieved binocular Uncorrected near Visual Acuity (UNVA) of 0.8 or better and 93% achieved 0.5 or better. No eyes lost more than one line of BCVA and there were no serious complications after surgery. Mini-monovision peripheral presbyLASIK was safe, effective and highly predictable for myopic presbyopes.
What problem does this paper attempt to address?